1Isgar B, Harman M,Kaye D, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut,1983,24:190-192.
2Coates MD, Mahoney CR, Linden DR. et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology,2004,126:1657-1664.
3Magro F, Vieira-Coelho MA, Fraga S, et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci, 2002,47:216-224.
5Minderhoud IM, Oldenburg B, Wismeijer JA. et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci,2004,49:469-474.
7FERRANTE M, VAN ASSCHE G. Medical therapy andmucosal healing [ J ]. . Curr Drug Targets, 2012, 13 ( 10 ):1294 -1299.
8ARDIZZONE S, CASSINOTTI A, DUCA P. mucosalhealng predicts late outcomes after the first course or corti-costeroids for newly kiagnosed ulcerative cokitis [ J ]. ClinGastroenterol Hepatol,2011,9(6) :483 -489.
9Saito YA,Schoenfeld P,Locke GR 3rd.The epidemiology ofirritable bowel syndrome in North America:a systematicreview.Am J Gastroenterol,2002 ; 97:1910-1915.
